Electroanalysis of sars-cov-2 specific igg and igm antibodies at microfluidic paper-based devices

dc.contributor.advisorPokpas, Keagan
dc.contributor.authorDu Plooy, Jarid
dc.date.accessioned2023-02-20T07:25:10Z
dc.date.accessioned2024-05-09T10:51:09Z
dc.date.available2024-05-09T10:51:09Z
dc.date.issued2022
dc.description>Magister Scientiae - MScen_US
dc.description.abstractThe Covid-19 pandemic has taken the world by storm. The infectious disease, SARS-CoV-2, was caused by a newly found virus of the corona family. With over 6 million deaths worldwide, it is evident that the SARS-CoV-2 virus is deadly. This has placed world-wide health sectors under strain, working tirelessly toward effective vaccinations, treatments and monitoring. Further research into development of more rapid, low-cost, sensitive and reliable point-of-care (POC) SARS-CoV-2 devices is required to meet the needs of developing regions and tailor vaccine antibody production to prevent further spread of the disease. Moreover, carbon-based nanostructured materials have shown to improve biosensor detection capabilities with increased electron-transfer kinetics and active surface area resulting in more effective immobilizations of antibody/antigen onto modified electrodes surface.en_US
dc.description.embargo2026
dc.identifier.urihttps://hdl.handle.net/10566/14583
dc.language.isoenen_US
dc.publisherUniversity of the Western Capeen_US
dc.rights.holderUniversity of the Western Capeen_US
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2en_US
dc.subjectCovid-19en_US
dc.subjectPublic healthen_US
dc.subjectChemistryen_US
dc.titleElectroanalysis of sars-cov-2 specific igg and igm antibodies at microfluidic paper-based devicesen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
du plooy_m_nsc_2022_36.pdf
Size:
5.85 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: